These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 27872733)
1. Hyperhemolytic Syndrome Complicating a Delayed Hemolytic Transfusion Reaction due to anti-P1 Alloimmunization, in a Pregnant Woman with HbO-Arab/β-Thalassemia. Bezirgiannidou Z; Christoforidou A; Kontekaki E; Anastasiadis AG; Papamichos SI; Menexidou H; Margaritis D; Martinis G; Mantadakis E Mediterr J Hematol Infect Dis; 2016; 8(1):e2016053. PubMed ID: 27872733 [TBL] [Abstract][Full Text] [Related]
2. An Unusual Case of Delayed Hemolytic Transfusion Reaction With Hyperhemolysis Syndrome Due to Anti-Jk El Alaoui K; Benghiat FS; Colard M J Hematol; 2022 Apr; 11(2):66-70. PubMed ID: 35573755 [TBL] [Abstract][Full Text] [Related]
3. Delayed hemolytic transfusion reaction/hyperhemolysis syndrome in children with sickle cell disease. Talano JA; Hillery CA; Gottschall JL; Baylerian DM; Scott JP Pediatrics; 2003 Jun; 111(6 Pt 1):e661-5. PubMed ID: 12777582 [TBL] [Abstract][Full Text] [Related]
4. Delayed Hemolytic Transfusion Reaction With Hyperhemolysis Syndrome Due to Anti-M Alloantibody in Myelofibrosis: A Case Report. Alsoreeky MS; Lutfi LK; Altamimi AA; Haddad TH; Khalayleh MS; Alkader MS Cureus; 2023 Dec; 15(12):e50717. PubMed ID: 38234941 [TBL] [Abstract][Full Text] [Related]
5. Anti-N and anti-Do Unnikrishnan A; Pelletier JPR; Bari S; Zumberg M; Shahmohamadi A; Spiess BD; Michael MJ; Harris N; Harrell D; Mandernach MW Transfusion; 2019 Jun; 59(6):1907-1910. PubMed ID: 30768787 [TBL] [Abstract][Full Text] [Related]
6. Delayed Severe Hemolytic Transfusion Reaction During Pregnancy in a Woman with β-Thalassemia Intermediate: Successful Outcome After Eculizumab Administration. Cannas G; Dubreuil L; Fichez A; Gerfaud-Valentin M; Debard AL; Hot A Am J Case Rep; 2021 May; 22():e931107. PubMed ID: 33983909 [TBL] [Abstract][Full Text] [Related]
7. Delayed hemolytic transfusion reaction with hyperhemolysis after first red blood cell transfusion in child with beta-thalassemia: challenges in treatment. Hannema SE; Brand A; van Meurs A; Smiers FJ Transfusion; 2010 Feb; 50(2):429-32. PubMed ID: 19788508 [TBL] [Abstract][Full Text] [Related]
8. Hyperhemolytic Transfusion Reaction in Non-Hemoglobinopathy Patients and Terminal Complement Pathway Activation: Case Series and Review of the Literature. Cid J; Fernández J; Palomo M; Blasco M; Bailó N; Diaz-Ricart M; Lozano M Transfus Med Rev; 2020 Jul; 34(3):172-177. PubMed ID: 32703665 [TBL] [Abstract][Full Text] [Related]
9. Recurrent hyperhemolytic transfusion reaction in myelodysplastic syndrome- A case based approach. Augustine M; Murugesan M; Nair CK; Raghavan V; Nayanar SK Transfus Apher Sci; 2021 Jun; 60(3):103073. PubMed ID: 33581999 [TBL] [Abstract][Full Text] [Related]
10. Hyperhemolysis syndrome in a patient without a hemoglobinopathy, unresponsive to treatment with eculizumab. Gupta S; Fenves A; Nance ST; Sykes DB; Dzik WS Transfusion; 2015 Mar; 55(3):623-8. PubMed ID: 25257194 [TBL] [Abstract][Full Text] [Related]
12. Treatment with intravenous immunoglobulin and steroids may correct severe anemia in hyperhemolytic transfusion reactions: case report and literature review. Win N; Sinha S; Lee E; Mills W Transfus Med Rev; 2010 Jan; 24(1):64-7. PubMed ID: 19962576 [TBL] [Abstract][Full Text] [Related]
13. Two Consecutive Episodes of Severe Delayed Hemolytic Transfusion Reaction in a Sickle Cell Disease Patient. Mpinganzima C; Haaland A; Holm AGV; Thein SL; Tjønnfjord GE; Iversen PO Case Rep Hematol; 2020; 2020():2765012. PubMed ID: 32351743 [TBL] [Abstract][Full Text] [Related]
14. Delayed Hemolytic Transfusion Reaction in a Sickle Cell Disease Patient: A Case Report. Saleh M; Mallipeddi VP; Ali A Cureus; 2020 Dec; 12(12):e12167. PubMed ID: 33489579 [TBL] [Abstract][Full Text] [Related]
15. Successful Outcome of Hyperhemolysis in Sickle Cell Disease following Multiple Lines of Treatment: The Role of Complement Inhibition. Vlachaki E; Gavriilaki E; Kafantari K; Adamidou D; Tsitsikas D; Chasapopoulou E; Anagnostopoulos A; Tsapas A Hemoglobin; 2018; 42(5-6):339-341. PubMed ID: 30626228 [TBL] [Abstract][Full Text] [Related]
16. An Unusual Case of Hyperhemolysis Syndrome and Delayed Hemolytic Transfusion Reaction due to Anti-Jk(a) and Anti-P1 Antibodies. Montgomery H; Luo MX; Baker S; Lim MY Case Rep Med; 2023; 2023():5290115. PubMed ID: 38188902 [TBL] [Abstract][Full Text] [Related]
17. Hyperhemolysis syndrome in anemia of chronic disease. Darabi K; Dzik S Transfusion; 2005 Dec; 45(12):1930-3. PubMed ID: 16371046 [TBL] [Abstract][Full Text] [Related]
18. Acute Hyperhemolysis Syndrome in a Patient with Known Sickle Cell Anemia Refractory to Steroids and IVIG Treated with Tocilizumab and Erythropoietin: A Case Report and Review of Literature. Menakuru SR; Priscu A; Dhillon V; Salih A Hematol Rep; 2022 Jul; 14(3):235-239. PubMed ID: 35893156 [TBL] [Abstract][Full Text] [Related]
19. Red blood cell alloimmunization and delayed hemolytic transfusion reactions in patients with sickle cell disease. Balbuena-Merle R; Hendrickson JE Transfus Clin Biol; 2019 May; 26(2):112-115. PubMed ID: 30857806 [TBL] [Abstract][Full Text] [Related]
20. Study of red blood cell alloimmunization risk factors in multiply transfused thalassemia patients: role in improving thalassemia transfusion practice in Fayoum, Egypt. Abdelrazik AM; Elshafie SM; El Said MN; Ezzat Ahmed GM; Al-Gamil AK; El Nahhas MG; Sady AA Transfusion; 2016 Sep; 56(9):2303-7. PubMed ID: 27351342 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]